BioSpace News Archive

Sigilon Therapeutics, Inc. announced that the Medicines and Healthcare Products Regulatory Agency in the United Kingdom has accepted the Company’s Clinical Trial Application for SIG-005 in Mucopolysaccharidosis Type I, a chronic, progressive lysosomal disease.

Zentalis Pharmaceuticals, Inc. today announced that six abstracts have been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) Congress, being held virtually September 16-21, 2021.

Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced that it has entered into an agreement with Vizient to offer XENLETA, which treats community-acquired bacterial pneumonia, as a contracted product to Vizient’s Pharmacy Network Program.

Precision BioSciences today provided strategic business updates on its in vivo gene editing pipeline during the Company’s first gene editing R&D event.

Positive high-level results from the MANDALA and DENALI Phase III trials of PT027.

Rallybio today reported its financial results for the second quarter ended June 30, 2021 and provided an update on recent corporate developments.

The rising technological advancements across the dental sector are increasing the growth prospects of the dental laboratories market to a great extent.

Fact.MR – A Market Research and Competitive Intelligence Provider: Increasing cases of cardiovascular diseases, rising geriatric population, and advancements in fluid management systems are pressing upon the need for advanced hemoconcentrators.

In the recent times, the global market for ambulatory health care services is registering a high profit. The increasing prevalence of chronic diseases across the world is the main factor that is fueling the demand for ambulatory health care services, globally.

The super-resolution microscopes market is growing on the back of technological advancements.